Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]F-AraG Kinetics and Safety in Healthy Volunteers
NCT02323893Phase 1Completed
- Sponsor
- CellSight Technologies
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by CellSight Technologies. Primary endpoints: Visualize biodistribution of the PET tracer [18F]F-AraG at 1 day, Analyze human dosimetry of [18F]F-AraG at 1 day and 1 more. Started Feb 2015; status: completed.
Beyond the preview
Go deeper on NCT02323893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323893.